Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.
Servycal offers quality control and development services tailored for the pharmaceutical sector, with a particular focus on the oncology industry. The company specializes in providing cancer therapy products, including cytotoxics, anti-hormonal treatments, and supportive therapies. By ensuring high standards in product development and quality assurance, Servycal aims to enhance the efficacy and safety of oncology treatments.
Laboratorios Klinger
Acquisition in 2004
Laboratorios Klinger operates as a generic and OTC drug marketer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.